Key summary points
To identify the associations between probable sarcopenia and common geriatric syndromes in a sample of community-dwelling older adults.
AbstractSection FindingsThe prevalence of probable sarcopenia was 12.7%; frailty, male sex and chronic kidney disease were identified as independent associations of sarcopenia.
AbstractSection MessageFrailty screening should be carried out and comorbidity status should be identified in the presence of probable sarcopenia without waiting for loss of muscle mass to ensure the early application of appropriate measures.
Abstract
Purpose
EWGSOP2 defines “probable sarcopenia” as the presence of low muscle strength without non-muscle causes. The associations of probable sarcopenia have been studied in few reports to date, and our intention in this study is to identify associations of probable sarcopenia with common geriatric syndromes in a sample of older adults who attended the geriatric outpatient clinic of Istanbul University Hospital.
Methods
The present study was designed as a retrospective cross-sectional study. We performed a comprehensive geriatric assessment to the participants. Univariate analyses were performed to determine relationship of probable sarcopenia with age, sex, common geriatric syndromes, i.e., frailty, falls, polypharmacy, malnutrition, and comorbidities, i.e., diabetes mellitus, hypertension, chronic kidney disease, chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), depression, osteoporosis, and the variables found to be significant were included in logistic regression analyses. The results are presented as an odds ratio (OR), with a 95% confidence interval (CI).
Results
Included in the study were 456 participants with a mean age of 74.6 ± 6.6 years, of which 71.1% were female. Probable sarcopenia was identified in 12.7% (n = 58) of the sample. A multivariate analysis was carried out, the factors associated with probable sarcopenia were identified as male sex (OR 0.269, 95% CI 0.142–0.510), frailty (OR 4.265, 95% CI 2.200–8.267) and chronic kidney disease (OR 3.084, 95% CI 1.105–8.608).
Conclusion
Probable sarcopenia was more significantly associated with frailty than with other geriatric syndromes, signifying its importance as a marker for frailty. The study further identified chronic renal failure as a factor significantly associated with probable sarcopenia among the variety of studied diseases that frequently accompany aging.
Similar content being viewed by others
Data availability
Data are available from the authors upon reasonable request.
References
Marzetti E, Calvani R, Tosato M et al (2017) SPRINTT Consortium sarcopenia: an overview. Aging Clin Exp Res 29(1):11–17
Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39:412–423
Bahat G, Tufan A, Kilic C et al (2019) Cut-off points for weight and body mass index adjusted bioimpedance analysis measurements of muscle mass. Aging Clin Exp Res 31(7):935–942
Bahat G, Kilic C, Ilhan B et al (2019) Association of different bioimpedanciometry estimations of muscle mass with functional measures. Geriatr Gerontol Int 19(7):593–597
Bahat G, Tufan A, Kilic C et al (2020) Cut-off points for height, weight and body mass index adjusted bioimpedance analysis measurements of muscle mass with use of different threshold definitions. Aging Male 23(5):382–387
Mayhew AJ, Amog K, Phillips S et al (2018) The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing 48:48–56
Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31
Beaudart C, Zaaria M, Pasleau F et al (2017) Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS ONE 12(1):e0169548
Landi F, Liperoti R, Fusco D et al (2012) Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc 13:121–126
Studenski S, Perera S, Patel K et al (2011) Gait speed and survival in older adults. JAMA 305:50–58
Huang P, Luo K, Xu J et al (2021) Sarcopenia as a risk factor for future hip fracture: a meta-analysis of prospective cohort studies. J Nutr Health Aging 25:183–188
Bahat G, Tufan A, Kilic C et al (2020) Prevalence of sarcopenia and its components in community-dwelling outpatient older adults and their relation with functionality. Aging Male 23(5):424–430
Volaklis KA, Halle M, Thorand B et al (2016) Handgrip strength is inversely and independently associated with multimorbidity among older women: results from the KORA-age study. Eur J Intern Med 31:35–40
Zhang XS, Liu YH, Zhang Y et al (2017) Handgrip strength as a predictor of nutritional status in Chinese elderly inpatients at hospital admission. Biomed Environ Sci 30(11):802–810
Dodds RM, Granic A, Robinson SM, Sayer AA (2020) Sarcopenia, long-term conditions, and multimorbidity: findings from UK biobank participants. J Cachexia Sarcopenia Muscle 11(1):62–68
Sousa-Santos AR, Afonso C, Borges N et al (2019) Factors associated with sarcopenia and undernutrition in older adults. Nutr Diet 76:604–612
Giglio J, Kamimura M, Lamarca F et al (2018) Association of sarcopenia with nutritional parameters, quality of life, hospitalization, and mortality rates of elderly patients on hemodialysis. J Ren Nutr 28(3):197–207
Pérez-Sousa MÁ, Pozo-Cruz JD, Cano-Gutiérrez CA et al (2021) High prevalence of probable sarcopenia in a representative sample from Colombia: implications for geriatrics in latin America. J Am Med Dir Assoc 22(4):859-864.e1
Katz S, Ford AB, Moskowitz RW et al (1963) Studies of illness in the aged the Index of Adl: a standardized measure of biological and psychosocial function. JAMA 185:914–919
Lawton MP, Brody EM (1969) Assessment of older people: self-management. Gerontologist 9:179–186
Guigoz Y, Vellas B, Garry PJ (1996) Assessing the nutritional status of the elderly: the mini nutritional assessment as part of the geriatric evaluation. Nutr Rev 54:59–65
Rubenstein LZ, Harker JO, Salvà A et al (2001) Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol: Ser A 56:366–372
Ferner RE, Aronson JK (2006) Communicating information about drug safety. BMJ 333:143–145
Morley JE, Malmstrom TK, Miller DK (2012) A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging 16:601–608
Fess EE. Grip strength. In. Casanova JS, ed. Clinical Assessment Recommendations, 41–5.
Massy-Westropp NM, Gill TK, Taylor AW, Bohannon RW, Hill CL (2011) Hand grip strength: age and gender stratified normative data in a population-based study. BMC Res Notes 4:127
Wearing J, Konings P, de Bie RA et al (2020) Prevalence of probable sarcopenia in community-dwelling older Swiss people—-a cross-sectional study. BMC Geriatr 20(1):307
Sobestiansky S, Michaelsson K, Cederholm T (2019) Sarcopenia prevalence and associations with mortality and hospitalisation by various sarcopenia definitions in 85–89 year old community-dwelling men: a report from the ULSAM study. BMC Geriatr 19(1):318
Tsekoura M, Billis E, Matzaroglou C et al (2021) Prevalence of probable sarcopenia in community-dwelling older Greek people. J Frailty Sarcopenia Falls. 6(4):204–208
Marincolo JCS, Aprahamian I, Corona LP et al (2021) Three definitions of probable sarcopenia and associations with falls and functional disability among community-dwelling older adults. Osteoporos Sarcopenia 7(2):69–74
Cipolli GC, Aprahamian I, Borim FSA et al (2021) Probable sarcopenia is associated with cognitive impairment among community-dwelling older adults: results from the FIBRA study. Arq Neuropsiquiatr 79(5):376–383
Clegg A, Young J, Iliffe S et al (2013) Frailty in elderly people. Lancet 381:752–762
Cruz-Jentoft AJ, Kiesswetter E, Drey M, Sieber CC (2017) Nutrition, frailty, and sarcopenia. Aging Clin Exp Res 29(1):43–48
Samper-Ternent R, Reyes-Ortiz C, Ottenbacher KJ et al (2016) Frailty and sarcopenia in Bogotá: results from the SABE Bogotá Study. Aging Clin Exp Res 29(2):265–272
Bahat G, Kilic C, Altinkaynak M et al (2020) Comparison of standard versus population-specific handgrip strength cut-off points in the detection of probable sarcopenia after launch of EWGSOP2. Aging Male 23(5):1564–1569
Vermeiren S, Vella-Azzopardi R, Beckwée D et al (2016) Frailty and the prediction of negative health outcomes: a meta-analysis. J Am Med Dir Assoc 17(12):1163.e1-1163.e17
Beaudart C, McCloskey E, Bruyère O et al (2016) Sarcopenia in daily practice: assessment and management. BMC Geriatr 16(1):170
Wang XH, Mitch WE (2014) Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol 10:504–516
Isoyama N, Qureshi A, Avesani C et al (2014) Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol 9(10):1720–1728
Kittiskulnam P, Chertow G, Carrero J et al (2017) Sarcopenia and its individual criteria are associated, in part with mortality among patients on hemodialysis. Kidney Int 92(1):238–247
D’Alessandro C, Piccoli GB, Barsotti M et al (2018) Prevalence and correlates of sarcopenia among elderly CKD outpatients on tertiary care. Nutrients 10(12):1951
Lamarca F, Carrero JJ, Rodrigues JC et al (2014) Prevalence of sarcopenia in elderly maintenance hemodialysis patients: the impact of different diagnostic criteria. J Nutr Health Aging 18(7):710–717
Pereira RA, Cordeiro AC, Avesani CM et al (2015) Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transplant 30(10):1718–1725
Wilkinson TJ, Miksza J, Yates T, Lightfoot CJ, Baker LA, Watson EL, Zaccardi F, Smith AC (2021) Association of sarcopenia with mortality and end-stage renal disease in those with chronic kidney disease: a UK biobank study. J Cachexia Sarcopenia Muscle 12(3):586–598
Noncommunicable diseases: risk factors. In: Global Health Observatory [website]. Geneva: World Health Organization; 2022 (https://www.who.int/data/gho/data/themes/topics/noncommunicable-diseases-risk-factors)
Satman I, Omer B, Tutuncu Y et al (2013) Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 28(2):169–180
Sugimoto K, Tabara Y, Ikegami H et al (2019) Hyperglycemia in non-obese patients with type 2 diabetes is associated with low muscle mass: the multicenter study for clarifying evidence for sarcopenia in patients with diabetes mellitus. J Diabetes Investig 10:1471–1479
Liccini A, Malmstrom TK (2016) Frailty and sarcopenia as predictors of adverse health outcomes in persons with diabetes Mellitus. J Am Med Dir Assoc 17:846–851
de Freitas MM, de Oliveira VLP, Grassi T et al (2020) Difference in sarcopenia prevalence and associated factors according to 2010 and 2018 European consensus (EWGSOP) in elderly patients with type 2 diabetes mellitus. Exp Gerontol 132:110835
Anagnostis P, Gkekas NK, Achilla C et al (2020) Type 2 diabetes mellitus is associated with increased risk of sarcopenia: a systematic review and meta-analysis. Calcif Tissue Int 107:453–463
Izzo A, Massimino E, Riccardi G, Della PG (2021) A narrative review on sarcopenia in type 2 diabetes mellitus: prevalence and associated factors. Nutrients 13(1):183
Remelli F, Maietti E, Abete P et al (2022) Prevalence of obesity and diabetes in older people with sarcopenia defined according to EWGSOP2 and FNHI criteria. Aging Clin Exp Res 34(1):113–120
Çeliker M, Selçuk MY, Olt S (2018) Sarcopenia in diabetic nephropathy: a cross-sectional study. Rom J Intern Med 56:102–108
van Bakel SIJ, Gosker HR, Langen RC, Schols AMWJ (2021) Towards personalized management of sarcopenia in COPD. Int J Chron Obstruct Pulmon Dis 16:25–40
Zhang Y, Zhang J, Ni W et al (2021) Sarcopenia in heart failure: a systematic review and meta-analysis. ESC Heart Fail 8(2):1007–1017
Hanada M, Sakamoto N, Ishimatsu Y et al (2016) Effect of long-term treatment with corticosteroids on skeletal muscle strength, functional exercise capacity and health status in patients with interstitial lung disease. Respirology 21(6):1088–1093
Langen RC, Gosker HR, Remels AH, Schols AM (2013) Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease. Int J Biochem Cell Biol 45(10):2245–2256
Budui SL, Rossi AP, Zamboni M (2015) The pathogenetic bases of sarcopenia. Clin Cases Miner Bone Metab 12:22–26
Delibaş DH, Eşkut N, İlhan B et al (2021) Clarifying the relationship between sarcopenia and depression in geriatric outpatients. Aging Male 24(1):29–36
Byeon CH, Kang KY, Kang SH et al (2016) Sarcopenia is not associated with depression in Korean adults: results from the 2010–2011 Korean national health and nutrition examination survey. Korean J Fam Med 37:37–43
Anderson LJ, Liu H, Garcia JM (2017) Sex differences in muscle wasting. Adv Exp Med Biol 1043:153–197
Tseng LA, Delmonico MJ, Visser M et al (2014) Body composition explains sex differential in physical performance among older adults. J Gerontol Ser, Biol Sci Med Sci 69:93–100
Erbas Sacar D, Kilic C, Karan MA, Bahat G (2021) Ability of SARC-F to find probable sarcopenia cases in older adults. J Nutr Health Aging 25(6):757–761
Beaudart C, Rizzoli R, Bruyère O et al (2014) Sarcopenia: burden and challenges for public health. Arch Public Health 72(1):45
Acknowledgements
Duygu Erbas Sacar, Cihan Kilic, Meryem Merve Oren, Tugba Erdogan, Serdar Ozkok, Caglar Ozer Aydın, Nezahat Muge Catikkas, Mehmet Akif Karan and Gulistan Bahat confirm their compliance with the ethical guidelines related to the authorship and publishing of the European Geriatric Medicine.
Funding
This research did not benefit from any specific grant from any funding agency operating in the public, commercial or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
DES: conceptualization, methodology, writing—original draft preparation, writing—review and editing, and formal analysis. CK: formal analysis. MMO: data curation and formal analysis. TE: data curation. SO: data curation. COA: data curation. NMC: data curation. MAK: writing—review and editing and supervision. GB: writing—review and editing and supervision. All the authors have read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
Ethical approval was granted by the Istanbul University Istanbul Medical School ethical Board.
Consent to participate
Informed consent was provided by all the participants.
Consent for publication
Informed consent for publication was provided by all the participants.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Erbas Sacar, D., Kılıc, C., Oren, M.M. et al. Probable sarcopenia: associations with common geriatric syndromes and comorbidities in Turkish geriatric patients from a university hospital. Eur Geriatr Med 13, 1299–1308 (2022). https://doi.org/10.1007/s41999-022-00691-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s41999-022-00691-9